Senseonics Announces Equity Grants To Employees Under Inducement Plan
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a...
Day: July 3, 2019
Ad hoc: MorphoSys Increases Financial Guidance for 2019 Following a Milestone Payment for Antibody Otilimab (MOR103/GSK3196165) by GSK
PLANEGG and MUNICH, GERMANY / ACCESSWIRE / July 3, 2019 / MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX &...
MorphoSys’s Licensing Partner GSK Initiates Phase 3 Clinical Program With Otilimab (MOR103/GSK3196165) in Rheumatoid Arthritis; MorphoSys Updates its Financial Guidance for 2019
PLANEGG and MUNICH, GERMANY / ACCESSWIRE / July 3, 2019 / MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX &...
Experion Holdings Ltd. Trading on Frankfurt Stock Exchange Under New Company Name
VANCOUVER, BC / ACCESSWIRE / July 3, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSXV: EXP) (OTCQB:EXPFF) (FRANKFURT:MB31),...
Evotec Completes Acquisition Of Just Biotherapeutics
ACQUISITION EXTENDS EVOTEC'S MULTIMODALITY OFFERING, WITH INTEGRATED SOLUTIONS FOR SMALL MOLECULES AND BIOLOGICS EXPANDS EVOTEC'S US FOOTPRINT IN SEATTLE AND...